Recursion Pharmaceuticals Inc (RXRX)
5.695
-0.06
(-0.96%)
USD |
NASDAQ |
Nov 22, 16:00
5.75
+0.06
(+0.97%)
After-Hours: 20:00
Recursion Pharmaceuticals Shareholders Equity (Quarterly): 524.56M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 524.56M |
| June 30, 2024 | 584.45M |
| March 31, 2024 | 401.15M |
| December 31, 2023 | 463.44M |
| September 30, 2023 | 437.97M |
| June 30, 2023 | 468.96M |
| March 31, 2023 | 430.18M |
| December 31, 2022 | 485.81M |
| Date | Value |
|---|---|
| September 30, 2022 | 388.03M |
| June 30, 2022 | 437.58M |
| March 31, 2022 | 493.57M |
| December 31, 2021 | 542.94M |
| September 30, 2021 | 599.03M |
| June 30, 2021 | 642.71M |
| March 31, 2021 | -233.03M |
| December 31, 2020 | -206.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-233.03M
Minimum
Mar 2021
642.71M
Maximum
Jun 2021
403.82M
Average
466.20M
Median
Shareholders Equity (Quarterly) Benchmarks
| Revance Therapeutics Inc | -163.03M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 726.50M |
| Total Liabilities (Quarterly) | 201.94M |
| Debt to Equity Ratio | 0.0548 |
| Current Ratio | 4.355 |
| Net Debt Paydown Yield | -0.29% |